Free Trial

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group logo
$295.60 -5.13 (-1.71%)
Closing price 03:59 PM Eastern
Extended Trading
$295.80 +0.20 (+0.07%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
3
Buy
16

Based on 19 Wall Street analysts who have issued ratings for Cigna Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 3 have given a hold rating, 14 have given a buy rating, and 2 have given a strong buy rating for CI.

Consensus Price Target

$372.69
26.08% Upside
According to the 19 analysts' twelve-month price targets for Cigna Group, the average price target is $372.69. The highest price target for CI is $415.00, while the lowest price target for CI is $323.00. The average price target represents a forecasted upside of 26.08% from the current price of $295.60.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cigna Group and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CI Analyst Ratings Over Time

TypeCurrent Forecast
10/13/24 to 10/13/25
1 Month Ago
9/13/24 to 9/13/25
3 Months Ago
7/15/24 to 7/15/25
1 Year Ago
10/14/23 to 10/13/24
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
14 Buy rating(s)
15 Buy rating(s)
16 Buy rating(s)
13 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$372.69$374.76$380.39$392.79
Forecasted Upside26.08% Upside23.80% Upside25.78% Upside12.13% Upside
Consensus RatingModerate BuyBuyBuyBuy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cigna Group Stock vs. The Competition

TypeCigna GroupMedical CompaniesS&P 500
Consensus Rating Score
2.95
2.33
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside23.82% Upside1,036.11% Upside177.79% Upside
News Sentiment Rating
Positive News

See Recent CI News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/8/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingHold (C+)
10/7/2025Wells Fargo & Company
3 of 5 stars
Stephen Baxter
Stephen Baxter
4 of 5 stars
Boost TargetEqual Weight$340.00 ➝ $354.00+16.72%
9/4/2025Barclays
3 of 5 stars
Andrew Mok
Andrew Mok
Not Rated
Boost TargetOverweight$354.00 ➝ $383.00+27.59%
9/2/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Target$375.00+24.76%
8/26/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$365.00+21.33%
8/14/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Target$372.00+29.69%
8/5/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set TargetBuy$415.00+53.04%
8/4/2025Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$388.00 ➝ $350.00+33.08%
6/26/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$371.00+12.45%
6/23/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
5/5/2025Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
5/5/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$348.00 ➝ $374.00+12.09%
5/5/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$379.00 ➝ $390.00+16.04%
4/9/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOutperform$360.00 ➝ $384.00+22.66%
2/6/2025Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformMarket Perform$323.00+10.24%
2/3/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$410.00 ➝ $390.00+31.64%
1/31/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy$415.00 ➝ $360.00+21.26%
1/31/2025Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$400.00 ➝ $375.00+26.31%
1/31/2025Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$410.00 ➝ $380.00+28.89%
9/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$402.00 ➝ $422.00+16.25%
8/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$435.00 ➝ $438.00+27.49%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:26 PM ET.


Should I Buy Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 9, 2025. Please send any questions or comments about these Cigna Group pros and cons to contact@marketbeat.com.

Cigna Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in The Cigna Group:

  • The Cigna Group's quarterly revenue has increased by 11.0% compared to the same quarter last year, indicating strong growth potential.
  • The current stock price is around $306.57, which is positioned well within its 12-month range, suggesting stability and potential for appreciation.
  • The company has set its FY 2025 guidance at 29.600 EPS, showing confidence in future earnings performance.
  • The Cigna Group recently announced a quarterly dividend of $1.51 per share, providing a reliable income stream for investors, with an annualized yield of 1.9%.
  • Analysts have a generally positive outlook, with a majority rating the stock as a "Moderate Buy" and an average price target of $372.69, indicating potential upside.

Cigna Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in The Cigna Group for these reasons:

  • Insider selling activity has been noted, with a significant sale by an insider, which may raise concerns about the company's future prospects.
  • The stock has experienced fluctuations, with a 12-month high of $358.88 and a low of $256.89, indicating volatility that could deter risk-averse investors.
  • Some analysts have downgraded their ratings, reflecting mixed sentiments in the market regarding the stock's short-term performance.
  • The company's debt-to-equity ratio is 0.65, which, while manageable, suggests that the company is using a moderate amount of debt to finance its operations, potentially increasing financial risk.
  • The current ratio of 0.71 indicates that The Cigna Group may have liquidity concerns, as it suggests that current liabilities exceed current assets.

CI Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Cigna Group is $372.69, with a high forecast of $415.00 and a low forecast of $323.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cigna Group in the last year. There are currently 3 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CI shares.

According to analysts, Cigna Group's stock has a predicted upside of 26.08% based on their 12-month stock forecasts.

Cigna Group has been rated by research analysts at Barclays, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Guggenheim, Robert W. Baird, Truist Financial, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Cigna Group more than other "medical" companies. The consensus rating for Cigna Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CI compares to other companies.


This page (NYSE:CI) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners